Together With
Today is Thursday, June 18, 2026.
The Early Bird Index today is 89.60.
New to this newsletter? Sign up here
PRESENTED BY STRATIFIND
Can Precision Oncology Become More Precise? Stratifind Thinks So.
Cancer remains one of the largest and most important healthcare markets in the world, yet selecting the right treatment for the right patient remains one of oncology’s greatest challenges. Physicians routinely choose among chemotherapy, immunotherapy, targeted therapies, radiation, and combination approaches, often with limited information about which treatment is most likely to benefit a particular patient.
Stratifind is developing RainDanceEQ™, a precision oncology platform designed to help physicians make more informed treatment decisions through a more comprehensive understanding of each patient’s cancer. By integrating multiple layers of tumor information and advanced analytics into a single actionable report, the company aims to provide insights that go beyond traditional testing approaches.
Founded by healthcare investment banker Igor Sokolovsky and physician-scientist Dr. Partha Ray, Stratifind is pursuing an opportunity at the intersection of molecular diagnostics, precision medicine, and oncology decision support. Successful oncology diagnostics companies have created substantial value for patients, providers, and investors alike, and Stratifind seeks to establish a differentiated position within this growing sector.
The company is currently conducting a financing round through Netcapital and welcomes conversations with investors, family offices, healthcare professionals, and strategic partners interested in the future of cancer diagnostics and precision oncology.
Is Apple Fixing a Flop? 🤔
After experiencing awful iPhone Air sales, Apple $AAPL ( ▼ 1.1% ) might be planning a do-over to start fresh next year.
Details: Bloomberg reported on Wednesday that Apple is preparing its second-generation iPhone Air for spring 2027.
The company reportedly wants to improve the appeal of the slimmed-down device, with a new rear camera for ultrawide-angle photography.
Background: Apple released the iPhone Air in September 2025, and sales were weaker than expected. One report cited that it accounted for just 3% of total iPhone sales in that month, far behind the Pro models.
Sales were so bad that Apple cut production of the iPhone Air and reassessed its whole Air strategy this year.
Early Bird’s Nest Egg Gains: From an investor angle, the Air looks like a product-market-fit problem. Customers seem to prefer battery life, cameras, and price/value over extreme thinness.
If Apple revamps the Air line, the next version likely needs a better balance of features rather than just a thinner chassis.
Final Thoughts: Apple’s stock is up over 9% this year.
Notables
Notable Earnings Today: Kroger (NYSE: KR), Accenture (NYSE: ACN).
Notable IPOs Today: Plutonian Acquisition Corp II (NYSE: PLUN), First Carolina Financial Services, Inc. (NYSE: FCMB), Deep Fission, Inc. Common Stock (Nasdaq: FISN), Irenic Acquisition Corp. Class A Ordinary Shares (Nasdaq: IACQ), Kardigan, Inc. Common Stock (Nasdaq: KARD), Office Properties Income Trust Common shares of beneficial interest (Nasdaq: OPI), Texas Ventures Acquisition IV Corp Units (Nasdaq; TVIVU), Wilco 63 Corporation Units (Nasdaq: WLCOU).
Notable Equity Crowdfunding Campaigns Ending Today: N/A.
Notable Economic Events Today: Jobless Claims (8:30 a.m. ET), Philadelphia Fed Manufacturing Index (8:30 a.m. ET), Philly Fed Employment (8:30 a.m. ET), US Leading Index (10:00 a.m. ET), TIC Net Long-Term Transactions (4:00 p.m. ET), Fed's Balance Sheet (4:30 p.m. ET).
Bitcoin's Fed Meeting Stumble
After trying to spend the past few days with a price recovery, Bitcoin $BTC ( ▼ 1.36% ) fell 2% on Wednesday as traders grappled with Kevin Warsh’s first FOMC meeting.
Details: Hawkish messaging from the Fed on Wednesday resulted in added pressure on high-beta assets like Bitcoin.
Final Thoughts: Bitcoin’s price has been flat in the past week.
Smith & Wesson’s Strong Results
Firearm manufacturer Smith & Wesson Brands $SWBI ( ▼ 1.08% ) surged 18.47% in after-hours trading on Wednesday after reporting strong financial earnings results.
Financials: Smith & Wesson reported earnings of 36 cents per share in the past quarter and revenue of $178.4 million. Both were better than expected.
Final Thoughts: The stock has been rising this year and was previously up 37% in 2026 before these results.
Trends to Watch
Driving in Reverse: CarMax shares fall after used car retailer reports earnings beats, CEO details turnaround plan (CNBC)
Florida Vibes: Struggling JetBlue shuts down key Newark, LaGuardia operations as New York airport costs soar (New York Post)
Down to Earth: SpaceX Stock Continues Decline After Initial Spike (Futurism)
AI Pivot: Allbirds stock surges over 50% after company rebrands to Smartbird, appoints AWS exec as CEO (Yahoo! Finance)
Crypto Closure: Coinbase-Backed Crypto Perps Exchange Satori Finance Is Shutting Down (Decrypt)
Thank you for reading!
Forward to a friend and tell them to sign up here.
Pick winning stocks: Upgrade to Early Bird Prime.
Become a smarter investor: Get Early Bird Exclusives
Want more investing tips? Listen to the podcast.
Show Your Support: Buy Me a Coffee.
Questions or comments? Hit reply to reach out.
The contents of Early Bird are intended for informational and entertainment purposes only. They do not constitute trade or investment recommendations, and they are not financial or legal advice. Readers are encouraged to consult licensed professionals for personalized guidance regarding their financial or legal situations.
